Evidence map›Paper›PMID 29531730›Full record

ArticleClinical case reports2018

Direct Factor X sequestration by systemic amyloid light-chain amyloidosis.

Haruko Tashiro, Ryosuke Shirasaki, Masato Watanabe, Kazuo Kawasugi, Yoshihisa Takahashi, Naoki Shirafuji

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haruko TashiroDepartment of Hematology/Oncology Teikyo University School of Medicine Itabashi-ku Tokyo Japan.ORCID 0000-0002-9038-1710
Ryosuke ShirasakiDepartment of Hematology/Oncology Teikyo University School of Medicine Itabashi-ku Tokyo Japan.
Masato WatanabeDepartment of Pathology Teikyo University School of Medicine Itabashi-ku Tokyo Japan.
Kazuo KawasugiDepartment of Hematology/Oncology Teikyo University School of Medicine Itabashi-ku Tokyo Japan.
Yoshihisa TakahashiDepartment of Pathology Graduate School of Medical Sciences International University of Health and Welfare Narita Chiba Japan.
Naoki ShirafujiDepartment of Hematology/Oncology Teikyo University School of Medicine Itabashi-ku Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a lymphoplasmacytic lymphoma patient with Factor X (FX) deficiency. Despite the absence of FX inhibitor, the administration of fresh frozen plasma and anti-inhibitor coagulant complex did not increase the FX level. The autopsy showed that massive amyloid depositions to multiple organs and FX existed in union with amyloidosis.

Indexed as

Amyloid Light‐chain amyloidosisFactor X antibodyFactor X deficiencylymphoplasmacytic lymphoma

Identifiers

PMID29531730
PMCPMC5838284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.